<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for IMUC</title>
    <link />
    <description>Headlines for ImmunoCellular Therapeutics, Ltd.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/celldex-therapeutics-inc-cancer-therapy-cancer/6/17/2013/id/50331.aspx</link>
      <author>Minyanville</author>
      <pubDate>Mon, 17 Jun 2013 09:00:00 GMT</pubDate>
    </item>
    <item>
      <title>For Love And Money: 3 Growth Stocks From Casey's Alex Daley</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1502122-for-love-and-money-3-growth-stocks-from-casey-s-alex-daley.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 14 Jun 2013 08:44:30 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Announces Data Monitoring Committee Recommends Continuation of ICT-107 Phase II Trial</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3656974/immunocellular-announces-data-monitoring-committee-recommends-continuation-of-ict.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 07 Jun 2013 06:53:12 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics Announces Recommendation of Data Monitoring Committee to Continue ICT-10</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/07/immunocellular-therapeutics-announces-recommendati/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 07 Jun 2013 06:42:08 GMT</pubDate>
    </item>
    <item>
      <title>NeoStem's PCT Announces Manufacturing Deal with Immunocellular for Dendritic Cell Vaccines</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3640911/neostems-pct-announces-manufacturing-deal-with-immunocellular-for-dendritic-cell-.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 03 Jun 2013 07:33:25 GMT</pubDate>
    </item>
    <item>
      <title>DelMar Pharmaceuticals To Present Updated Phase I GBM Data At ASCO</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1470571-delmar-pharmaceuticals-to-present-updated-phase-i-gbm-data-at-asco.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 30 May 2013 11:48:27 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on May 30th</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/22/immunocellular-therapeutics-to-present-at-marcum-m/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 22 May 2013 06:20:54 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics Announces Issuance of Key Patent Covering ICT-107 Cancer Vaccine Target</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/16/immunocellular-therapeutics-announces-issuance-of-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 16 May 2013 06:17:49 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotech Stocks With Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1431871-3-biotech-stocks-with-potential.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 08:16:00 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics: Marching Toward Top Line Data For ICT-107 In Q4 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1424871-immunocellular-therapeutics-marching-toward-top-line-data-for-ict-107-in-q4-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 14:56:27 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics Announces First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/09/immunocellular-therapeutics-announces-first-quarte/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 09 May 2013 16:20:35 GMT</pubDate>
    </item>
    <item>
      <title>Northwest Biotherapeutics: Moving DC Vax-L Rapidly Forward And Starting DC Vax Direct Trials</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1411771-northwest-biotherapeutics-moving-dc-vax-l-rapidly-forward-and-starting-dc-vax-direct-trials.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 20:23:10 GMT</pubDate>
    </item>
    <item>
      <title>Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1399261-undervaluation-of-vical-s-full-pipeline-allows-a-cheap-bet-on-cancer-trial.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 12:15:10 GMT</pubDate>
    </item>
    <item>
      <title>With A New Institutional Investor On Board, Northwest Biotherapeutics Breaks The Curse</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1389001-with-a-new-institutional-investor-on-board-northwest-biotherapeutics-breaks-the-curse.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 10:37:39 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2013 May 9, 2013</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/01/immunocellular-therapeutics-to-report-financial-re/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 May 2013 06:19:54 GMT</pubDate>
    </item>
    <item>
      <title>The 9 Levels Of Biotechnology And Who Should Invest: Part 2</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1327331-the-9-levels-of-biotechnology-and-who-should-invest-part-2.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 12:16:09 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics to Present at Future Leaders Conference on April 5th</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/28/immunocellular-therapeutics-to-present-at-future-l/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 28 Mar 2013 06:14:42 GMT</pubDate>
    </item>
    <item>
      <title>Biotechnology Super Panel Talks Development, Marketing And The Future</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1304041-biotechnology-super-panel-talks-development-marketing-and-the-future.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Mar 2013 11:51:05 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1303681-immunocellular-therapeutics-a-close-look-at-key-issues-for-the-ongoing-phase-ii-trial-of-ict-107.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Mar 2013 10:32:05 GMT</pubDate>
    </item>
    <item>
      <title>ImmunoCellular Therapeutics to Present at ROTH Conference on March 18th</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/11/immunocellular-therapeutics-to-present-at-roth-con/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 11 Mar 2013 17:05:25 GMT</pubDate>
    </item>
  </channel>
</rss>
